AI in Healthcare: Accelerating Clinical Trials

Faro Health’s CEO and co-founder, Scott Chetham, joined Amar Drawid on the Life Sciences DNA Podcast to discuss how AI is actively transforming clinical trials today. In the episode, Scott explains how AI is improving core elements of clinical development—enhancing patient selection, strengthening feasibility assessments, and enabling more intelligent protocol design.

He highlights how these capabilities are already accelerating timelines, increasing precision, and reducing costs across the drug development process. Scott also shares Faro’s perspective that AI is becoming the connective layer that links scientific insight with operational speed, ushering in a new era of smarter, more adaptive clinical trials.

Tune into the full conversation to hear more about his vision and the future of AI-enabled clinical development.